These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8950841)

  • 1. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowel inflammation and the spondyloarthropathies.
    De Keyser F; Elewaut D; De Vos M; De Vlam K; Cuvelier C; Mielants H; Veys EM
    Rheum Dis Clin North Am; 1998 Nov; 24(4):785-813, ix-x. PubMed ID: 9891711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy.
    Lionetti P; Pupi A; Veltroni M; Fonda C; Cavicchi MC; Azzari C; Falcini F
    J Rheumatol; 2000 Jun; 27(6):1538-41. PubMed ID: 10852286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; Maertens M; Joos R
    J Rheumatol; 1993 Sep; 20(9):1567-72. PubMed ID: 8164217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.
    Mielants H; Veys EM; Goemaere S; Goethals K; Cuvelier C; De Vos M
    J Rheumatol; 1991 Oct; 18(10):1542-51. PubMed ID: 1765980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteropathic spondyloarthritis: from diagnosis to treatment.
    Peluso R; Di Minno MN; Iervolino S; Manguso F; Tramontano G; Ambrosino P; Esposito C; Scalera A; Castiglione F; Scarpa R
    Clin Dev Immunol; 2013; 2013():631408. PubMed ID: 23690825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: joint involvement in inflammatory bowel disease.
    De Vos M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowel lesions in spondyloarthritides.
    Rimbaş M; Marinescu M; Voiosu MR
    Rom J Intern Med; 2009; 47(1):75-85. PubMed ID: 19886073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Int J Clin Pharmacol Res; 1984; 4(6):409-14. PubMed ID: 6152438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ileocolonoscopic findings in seronegative spondylarthropathies.
    Mielants H; Veys EM; Cuvelier C; de Vos M
    Br J Rheumatol; 1988; 27 Suppl 2():95-105. PubMed ID: 3042080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spondyloarthropathies.
    Kataria RK; Brent LH
    Am Fam Physician; 2004 Jun; 69(12):2853-60. PubMed ID: 15222650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.